Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy
NICE Guidance, 2022
Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights
Digital Resources/Online E-Resources